Neurodegenerative Diseases

Neurodegenerative diseases affect more than 12 million people in Europe. They mainly affect people in the middle of their end-of-life and their incidence increases with the aging of the population since it is estimated that the number of people over 65 years old will represent a quarter of the European population by 2030.

Nervous system pathologies cost Europe nearly € 900 billion in 2015. They are now a major public health problem.

Most treatments today lack effectiveness, acting mainly on the symptoms and not on the causes of these diseases and their evolution. it is to make progress as quickly as possible and to make collaborate all the concerned teams that the program DHUNE was conceived.

Alzheimer’s Disease

> 220,000 new cases per year in France
> 12% of people over 65
> 0 healing treatment

Neurodegenerative disease leading to a gradual disappearance of neurons and causing impairment of cognition. It is the most common neurological disease.

Parkinson’s Disease

> 25,000 new cases a year in France
> average age: 58 years
> 0 healing treatment

The second most common neurological disease, it affects the central nervous system and causes physical and psychological disorders.

Multiple Sclerosis

Inflammatory disease, autoimmune demyelinating central nervous system, the most common in young adult. 1st cause of severe disability of non-traumatic origin in the thirties.

Lateral Amyotrophic Sclerosis Charcot Disease

> 8000 people in France
> 330 new cases in the world every day
> Average age: 45 years

A rare, fast-growing, incurable neurodegenerative disease that causes progressive motor impairment, including paralysis and death.

Huntington Disease

Hereditary neurodegenerative assignment leading to impaired physical and intellectual abilities and a loss of autonomy of the person.

Ageing

Natural process of life leading the body to no longer be able to perform its functions and its physiological balanceIt is estimated that the number of people aged over 65 will represent one quarter of the European population by 2030.